Background
Osteoarthritis (OA) is a prevalent degenerative joint disease that significantly impacts quality of life, particularly in older adults. Testosterone, a crucial hormone for musculoskeletal health, has been suggested to play a role in OA development. This study aims to investigate the relationship between low testosterone levels and the risk of OA in a nationally representative sample from NHANES (2011–2016).
Methods
This cross-sectional study utilized data from 4,548 participants in NHANES, excluding individuals with missing testosterone or OA data. Testosterone levels were categorized as low or normal, with low testosterone defined as less than 300 ng/dL for men. The presence of OA was based on self-reported physician diagnosis. Multivariable logistic regression models were used to analyze the association between testosterone levels and OA, adjusting for age, sex, race/ethnicity, education, marital status, income, smoking, alcohol consumption, hypertension, diabetes, hyperlipidemia, and BMI. Restricted cubic spline analysis was performed to explore non-linear associations. Subgroup analyses and interaction terms were included to assess effect modification.
Results
Among the 4,548 participants, 812 (17.9%) had OA. Participants with OA were older, predominantly female, and had higher rates of obesity, hyperlipidemia, and smoking compared to those without OA. Low testosterone levels were associated with a significantly increased risk of OA in unadjusted (OR, 2.22; 95% CI, 1.90–2.59; P < 0.001) and fully adjusted models (OR, 1.22; 95% CI, 1.02–1.46; P = 0.028). A non-linear relationship between testosterone levels and OA risk was observed, with increased OA risk at lower testosterone levels. Subgroup analyses indicated that the association between low testosterone and OA was consistent across demographic and clinical groups, with no significant interactions.
Conclusion
Low testosterone levels are independently associated with an increased risk of OA. This finding underscores the importance of hormonal health in OA pathogenesis and suggests that testosterone replacement therapy may be considered as a potential intervention to reduce OA risk in individuals with testosterone deficiency. Further longitudinal studies are warranted to explore the causal relationship between testosterone and OA.